Application of artificial intelligence technology in whole course management of colorectal cancer

Abstract

Abstract: With the rapid development of science and technology, artificial intelligence(AI) is much often experimentally used in the diagnosis, treatment, and prognosis prediction of many diseases. The principle of colorectal cancer treatment has changed from simply treating tumors to prolonging the patient's survival and improving their life quality. The concept of tumor overall management has thus being developed. In this paper, the development of AI technology in the whole course management of colorectal cancer is reviewed and through which to provide an outlook of prospecting a more deeply and widely use of AI technology in the whole course management of colorectal cancer.

Key words: whole course management, machine learning, colorectal cancer

CLC Number:

R616

WANG Pei-pei, WU Bin. Application of artificial intelligence technology in whole course management of colorectal cancer[J]. Basic & Clinical Medicine, 2020, 40(11): 1570-1573.

References

[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2020[J].2020,70: 7-30.
[2] Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014[J].Chin J Cancer Res,2018, 30: 1-12.
[3] Peek N, Combi C, Marin R, et al. Thirty years of artificial intelligence in medicine (AIME) conferences: a review of research themes[J]. Arti Intell Med,2015,65: 61-73.
[4] de Grey AD. artificial intelligence and medical research: time to aim higher?[J].Reju Res, 2016,19: 105-106.
[5] Trestini I, Carbognin L, Monteverdi S, et al. Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer[J].Crit Rev Onco/hema,2018,129: 54-66.
[6] Al-Haidari G, Skovlund E, Undseth C, et al. Re-irradiation for recurrent rectal cancer- a single-center experience[J].Acta Onco (Stockholm, Sweden),2020: 1-7.
[7] Balyasnikova S, Brown G. Optimal imaging strategies for rectal cancer staging and ongoing management[J]. Cur Treat Opti Onco,2016,17: 32-43.
[8] Castaneda C, Nalley K, Mannion C, et al. Cclinical decision support systems for improving diagnostic accuracy and achieving precision medicine[J]. J Clin Bio, 2015,5: 4-20.
[9] Tanaka S, Sano Y. Sim to unify the narrow band imaging magnifying classification for colorectal tumors: current status in Japan from a summary of the consensus symposium in the 79th annual meeting of the japan gastroenterological endoscopy society[J]. Dige Endo, 2011,23 Suppl 1: 131-139.
[10] Sano Y, Tanaka S, Kudo SE, et al. Narrow-band imaging magnifying endoscopic classification of colorectal tumors proposed by the Japan nbi expert team[J]. Dige Endo,2016: 28: 526-533.
[11] Chen PJ, Lin MC, Lai MJ, et al. Accurate classification of diminutive colorectal polyps using computer-aided analysis[J]. Gastroenterology,2018,154: 568-575.
[12] Misawa M, Kudo SE, Mori Y, et al. Artificial intelligence-assisted polyp detection for colonoscopy: initial experience[J]. Gastroenterology,2018,154: 2027-2029.
[13] Bang S, Yoo D, Kim SJ, et al. Establishment and evaluation of prediction model for multiple disease classification based on gut microbial data[J]. Sci Rep,2019, 9: 1018-1019.
[14] Kennedy ED, Simunovic M, Jhaveri K, et al. Safety and feasibility of using magnetic resonance imaging criteria to identify patients with “good prognosis” rectal cancer eligible for primary surgery: the phase 2 nonrandomized quicksilver clinical trial[J]. JAMA Onco, 2019, 5: 961-966.
[15] Ogawa S, Hida J, Ike H, et al. Selection of lymph node-positive cases based on perirectal and lateral pelvic lymph nodes using magnetic resonance imaging: study of the japanese society for cancer of the colon and rectum[J]. Ann Surg Onco,2016, 23: 1187-1194.
[16] Ren S, He K, Girshick R, et al.Faster r-cnn: towards real-time object detection with region proposal networks[J]. IEEE Trans Patt Anal and Mach Intell, 2017,39: 1137-1149.
[17] 周云朋, 李硕, 卢云,等.基于深度神经网络的高分辨MRI直肠淋巴结辅助诊断系统的临床应用价值研究[J] 中华外科杂志, 2019,57: 108-113.
[18] Ruffle JK, Farmer AD, Aziz Q. Artificial intelligence-assisted gastroenterology-promises and pitfalls[J]. Am J Gastroenter, 2019, 114: 422-428.
[19] Varghese AM, Cardin DB, Hersch J, et al. Phase i study of trifluridine/tipiracil plus irinotecan and bevacizumab in advanced gastrointestinal tumors[J]. Clin Cancer Res, 2020,26:1555-1562.
[20] Oyaga-Iriarte E, Insausti A, Sayar O, et al. Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters[J]. J Pharm Sci,2019,140: 20-25.
[21] Midura EF, Hanseman D, Davis BR, et al. Risk factors and consequences of anastomotic leak after colectomy: a national analysis[J]. Dis Colon Rectum, 2015; 58: 333-338.
[22] Sammour T, Hayes IP, Jones IT, et al. Impact of anastomotic leak on recurrence and survival after colorectal cancer surgery: a biogrid australia analysis[J]. ANZ J Surg,2018, 88: E6-E10.
[23] Sammour T, Cohen L, Karunatillake AI, et al. Validation of an online risk calculator for the prediction of anastomotic leak after colon cancer surgery and preli-minary exploration of artificial intelligence-based analytics[J]. Tech Colo, 2017,21: 869-877.
[24] Dimitriou N, Arandjelovic O, Caie PD. Deep learning for whole slide image analysis: an overview[J]. Fron Med, 2019, 6: 264-271.
[25] LeCun Y, Bengio Y, Hinton G. Deep learning[J]. Nature, 2015,521: 436-444.
[26] Bychkov D, Linder N, Turkki R, et al. Deep learning based tissue analysis predicts outcome in colorectal cancer[J]. Sci Rep,2018, 8: 3395-3406.